Polypharmacy and Risk of Antiretroviral Drug Interactions Among the Aging HIV-Infected Population

被引:0
|
作者
Carol Holtzman
Carl Armon
Ellen Tedaldi
Joan S. Chmiel
Kate Buchacz
Kathleen Wood
John T. Brooks
机构
[1] Temple University School of Pharmacy,
[2] Cerner Corporation,undefined
[3] Temple University School of Medicine,undefined
[4] Northwestern University,undefined
[5] Feinberg School of Medicine,undefined
[6] Centers for Disease Control and Prevention,undefined
来源
关键词
polypharmacy; drug interactions; HIV; aging;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1302 / 1310
页数:8
相关论文
共 50 条
  • [1] Polypharmacy and Risk of Antiretroviral Drug Interactions Among the Aging HIV-Infected Population
    Holtzman, Carol
    Armon, Carl
    Tedaldi, Ellen
    Chmiel, Joan S.
    Buchacz, Kate
    Wood, Kathleen
    Brooks, John T.
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2013, 28 (10) : 1302 - 1310
  • [2] Recognition of Risk for Clinically Significant Drug Interactions among HIV-Infected Patients Receiving Antiretroviral Therapy
    Evans-Jones, John G.
    Cottle, Lucy E.
    Back, David J.
    Gibbons, Sara
    Beeching, Nicholas J.
    Carey, Peter B.
    Khoo, Saye H.
    [J]. CLINICAL INFECTIOUS DISEASES, 2010, 50 (10) : 1419 - 1421
  • [3] CLINICALLY SIGNIFICANT DRUG INTERACTIONS AMONG HIV-INFECTED PATIENTS RECEIVING ANTIRETROVIRAL THERAPY
    So-Ngern, Apichot
    Montakantikul, Preecha
    Manosuthi, Weerawat
    [J]. SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2014, 45 (05) : 1023 - 1031
  • [4] Evolution of drug interactions with antiretroviral medications in HIV-infected patients
    El Moussaoui, M.
    Lambert, I.
    Maes, N.
    Sauvage, A-S
    Frippiat, F.
    Meuris, C.
    Uurlings, F.
    Lecomte, M.
    Philippe, L.
    Fombellida, K.
    Vaira, D.
    Vercheval, C.
    Moutschen, M.
    Darcis, G.
    [J]. HIV MEDICINE, 2019, 20 : 44 - 44
  • [5] Staging for antiretroviral therapy among HIV-infected drug users
    Wood, E
    Hogg, RS
    Bonner, S
    Kerr, T
    Li, K
    Palepu, A
    Guillemi, S
    Schechter, MT
    Montaner, JSG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (10): : 1175 - 1177
  • [6] Polypharmacy in the HIV-infected older adult population
    Gleason, Lauren J.
    Luque, Amneris E.
    Shah, Krupa
    [J]. CLINICAL INTERVENTIONS IN AGING, 2013, 8 : 749 - 763
  • [7] Polypharmacy and drug-drug interactions in HIV-infected subjects in the region of Madrid (Spain): a population-based study
    Lopez-Centeno, B.
    Badenes-Olmedo, C.
    Mataix-Sanjuan, A.
    McAllister, K.
    Bellon-Cano, J.
    Balsalobre, P.
    Benedi, J.
    Khoo, S.
    Calvo-Alcantara, M.
    Berenguer, J.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [8] Clinically significant drug interactions among HIV-infected patients receiving antiretroviral therapy in outpatient HIV clinic
    So-Ngern, A.
    Manosuthi, W.
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S72 - S72
  • [9] High frequency of polypharmacy and drug-drug interactions in an elderly HIV population on antiretroviral therapy
    Bourneau-Martin, D.
    Ruellan, A.
    Joyau, C.
    Secher, S.
    Allavena, C.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [10] Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients
    Allavena, Clotilde
    Hanf, Matthieu
    Rey, David
    Duvivier, Claudine
    BaniSadr, Firouze
    Poizot-Martin, Isabelle
    Jacomet, Christine
    Pugliese, Pascal
    Delobel, Pierre
    Katlama, Christine
    Joly, Veronique
    Chidiac, Christian
    Dournon, Nathalie
    Merrien, Dominique
    May, Thierry
    Reynes, Jacques
    Gagneux-Brunon, Amandine
    Chirouze, Catherine
    Huleux, Thomas
    Cabie, Andre
    Raffi, Francois
    [J]. PLOS ONE, 2018, 13 (09):